In the Press

Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology

The Glaucoma Treatment That Only Takes Seconds

Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.

Read this candid interview with CEO Daria Lemann-Blumenthal

Opinion piece on 'Glaucoma care in a matter of seconds'

Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.

BELKIN Vision Completes $12.25 Series B Financing Round

BELKIN Vision Announces $12.2M Raised in Series B Funding

Pushing Boundaries with Advanced Technologies

Company Showcase

Emerging Glaucoma Devices See Beyond IOP

BELKIN Vision COVID-19 update

New Technologies Change Glaucoma Treatment Paradigm

Glaucoma 360 forum provides Vision for 2020

Interview with CEO Daria Lemann-Blumenthall

US Edition Lindstrom's Opinion

Novel DSLT Taking aim at greater access to glaucoma care

Glaucoma Laser Developer BELKIN Vision raises $5M